What is the complete order set and management protocol for chest pain, including medication dosages and laboratory testing schedule?

Complete Order Set and Management Protocol for Chest Pain

For patients presenting with chest pain, immediately obtain a 12-lead ECG within 10 minutes of arrival, initiate continuous cardiac monitoring, establish IV access, and administer aspirin 162-325 mg (chewable preferred) unless contraindicated. 1, 2, 3

Initial Assessment and Triage (First 10 Minutes)

Immediate Actions

• ECG within ≤10 minutes of first medical contact 3, 4
• Continuous cardiac rhythm monitoring 5, 3
• Vital signs: blood pressure, heart rate, oxygen saturation, respiratory rate
• Aspirin 162-325 mg (chewable or water-soluble) immediately if ACS suspected 6, 5, 7
• IV access establishment
• Supplemental oxygen ONLY if oxygen saturation <90% or respiratory distress 1, 7

Focused Physical Examination

Look specifically for:

• Signs of hemodynamic instability (hypotension, pulmonary rales indicating heart failure)
• Cardiac auscultation for murmurs (aortic stenosis), gallops, rubs
• Jugular venous distension
• Unequal blood pressures or pulses (aortic dissection)
• Chest wall tenderness (musculoskeletal)
• Unilateral absent breath sounds (pneumothorax)

Laboratory Testing Schedule

Initial Blood Draw (Time Zero)

• High-sensitivity cardiac troponin (hs-cTn) - preferred biomarker 1, 2, 8
• Complete blood count (hemoglobin to detect anemia) 6, 5
• Basic metabolic panel (renal function for medication dosing)
• Lipid panel (preferably fasting, within 24 hours) 1, 7
• Coagulation studies if anticoagulation planned

Repeat Troponin Timing

Critical timing based on assay type:

• High-sensitivity troponin: Repeat at 1-3 hours from initial draw 1, 8
• Conventional troponin: Repeat at 3-6 hours from initial draw 1, 9, 8
• If both negative and low clinical suspicion: patient can be risk-stratified for discharge
• Do NOT use CK-MB or myoglobin - they are inferior to troponin 1

Medication Dosages and Administration

Anti-Ischemic Therapy

Nitroglycerin:

• Sublingual: 0.3-0.4 mg every 5 minutes × 3 doses for ongoing chest pain 1, 7
• IV nitroglycerin: Start 5-10 mcg/min, titrate by 5-10 mcg/min every 3-5 minutes for persistent ischemia, heart failure, or hypertension 7
• CONTRAINDICATED: If phosphodiesterase inhibitor use within 24 hours (sildenafil/vardenafil) or 48 hours (tadalafil) 1, 7

Beta-Blockers (initiate within first 24 hours if no contraindications):

• Metoprolol tartrate: 25-50 mg PO every 6-12 hours OR
• Metoprolol succinate: 25-100 mg PO daily (sustained-release) OR
• Carvedilol: 3.125-6.25 mg PO twice daily OR
• Bisoprolol: 2.5-5 mg PO daily
• DO NOT give IV beta-blockers if risk factors for shock present 1, 7
• Contraindications: heart failure, low-output state, cardiogenic shock risk, PR interval >0.24s, second/third-degree AV block without pacemaker

Calcium Channel Blockers (if beta-blockers contraindicated):

• Diltiazem: 30-60 mg PO every 6-8 hours (non-dihydropyridine preferred) OR
• Verapamil: 80-120 mg PO every 8 hours
• AVOID immediate-release nifedipine without concurrent beta-blocker 1, 7

Antiplatelet Therapy

Aspirin:

• Loading: 162-325 mg (chewable preferred for faster absorption) 7, 3
• Maintenance: 81 mg daily thereafter

P2Y12 Inhibitors (for confirmed NSTE-ACS):

• Ticagrelor: 180 mg loading dose, then 90 mg twice daily (preferred over clopidogrel) 3 OR
• Clopidogrel: 300-600 mg loading dose, then 75 mg daily (if ticagrelor unavailable or contraindicated) 6, 5 OR
• Prasugrel: 60 mg loading dose, then 10 mg daily (ONLY after coronary angiography, prior to PCI) 3
• Omit clopidogrel if CABG likely within 5 days 6

Anticoagulation

Unfractionated Heparin:

• Bolus: 60 units/kg IV (maximum 4000 units)
• Infusion: 12 units/kg/hour (maximum 1000 units/hour)
• Adjust to aPTT 1.5-2.5 times control

OR Low Molecular Weight Heparin:

• Enoxaparin: 1 mg/kg subcutaneous every 12 hours (adjust for renal function)

Statin Therapy

• High-intensity statin immediately: Atorvastatin 40-80 mg daily OR Rosuvastatin 20-40 mg daily 1, 7

Analgesia

• Morphine sulfate: 2-4 mg IV, may repeat every 5-15 minutes for refractory chest pain despite anti-ischemic therapy 1, 7
• Use cautiously - may be reasonable but not routinely recommended

Medications to AVOID

• NSAIDs (except aspirin): STOP immediately - increases MACE risk 1, 7

Risk Stratification and Observation Period

Serial ECG Monitoring

• Repeat ECG if symptoms recur or persist 4, 8
• Consider leads V7-V9 if posterior MI suspected 4, 8
• Compare with previous ECGs if available

Observation Duration: 6-12 Hours

Monitor for:

• Recurrent chest pain (obtain 12-lead ECG immediately)
• Dynamic ST-segment changes
• Hemodynamic instability
• Major arrhythmias (VT/VF)

Risk-Based Disposition Strategy

Very High Risk (Immediate Invasive Strategy <2 hours):

• Ongoing refractory ischemia
• Hemodynamic instability/cardiogenic shock
• Life-threatening arrhythmias (VT/VF)
• Mechanical complications → Immediate cardiac catheterization 3

High Risk (Early Invasive Strategy <24 hours):

• Elevated troponin
• Dynamic ST-segment changes (especially ST-depression or transient ST-elevation)
• GRACE score indicating high risk
• Diabetes mellitus
• Early post-MI unstable angina → Coronary angiography within 24 hours 3

Intermediate Risk (Invasive Strategy <72 hours):

• Normal troponin but intermediate clinical risk
• No recurrent symptoms → Coronary angiography within 72 hours 3

Low Risk (Selective Strategy):

• Normal serial troponins (at 0 and 1-3 hours for hs-cTn)
• Non-ischemic ECG
• No recurrent symptoms
• Low TIMI/GRACE score → Stress testing (exercise or pharmacologic) before discharge or within 72 hours as outpatient 1, 9, 8 → Can discharge with aspirin 81 mg daily, sublingual nitroglycerin, and outpatient follow-up 7

Critical Pitfalls to Avoid

1. Do not rely on single normal ECG - up to 6% of evolving ACS have normal initial ECG 4
2. Do not delay troponin retesting - timing is critical for rule-out protocols
3. Do not use routine supplemental oxygen in normoxic patients - may increase coronary vascular resistance 7
4. Do not give IV beta-blockers if any shock risk factors present
5. Do not discharge based solely on normal initial biomarkers - requires serial testing and risk stratification
6. Do not use CK-MB or myoglobin instead of troponin - inferior diagnostic accuracy 1

This protocol prioritizes rapid identification of life-threatening conditions while safely discharging low-risk patients, balancing mortality reduction with resource utilization.